• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Topical treatment of peri-implantitis with metronidazole dental gel 25%. Clinical analysis and microbiological control].

作者信息

Stellini E, Migliorato A, Mazzoleni S, Mottola A, Lombardi L, Favero G A

机构信息

Facoltà di Medicina e Chirurgia, Università degli Studi, Padova.

出版信息

Minerva Stomatol. 2000 Jan-Feb;49(1-2):59-67.

PMID:10932909
Abstract

BACKGROUND

Aim of this research is to verify the efficacy of metronidazole dental gel 25%, used as a topical antibiotic for the treatment of peri-implantitis. The efficacy of the medicine in the starting phase of the disease (mucositis), as well as during peri-implantitis involving bone-bearing loss has been evaluated.

METHODS

Twenty patients were chosen as a sample for the study. After careful evaluation of the several protocols concerning peri-implantitis treatment, some diagnostic clinical parameters have been recorded for each patient and metronidazole dental gel 25% (Elyzol Cabon) has been administered in two applications at perimplants pocket (one after a week). For each patient 3 microbiological drawings were made for the evaluation of the bacterial population around the implant site.

RESULTS

From the microbiological examination a decrease of Gram- and an increase of Gram+ which returned in almost all the patients to normal levels have been observed; moreover, in all the patients a gradual decrease of PMN, resolution index of the inflammatory process was obtained, confirmed also by a remarkable improvement of all the observed diagnostic parameters, except for the peri-implants bone radiotransparency which was unchanged.

CONCLUSIONS

The research showed that the peri-implant diseases can be positively resolved by using the metronidazole dental gel 25% topical antibiotic. This drug led to a 60-70% decrease of Gram-, and 40-50% increase for Gram+, bringing these back to normal values in almost all the patients. Moreover, a good recovery of the peri-implants soft tissues has been observed.

摘要

相似文献

1
[Topical treatment of peri-implantitis with metronidazole dental gel 25%. Clinical analysis and microbiological control].
Minerva Stomatol. 2000 Jan-Feb;49(1-2):59-67.
2
Long time follow up of implant therapy and treatment of peri-implantitis.种植体治疗及种植体周围炎治疗的长期随访
Swed Dent J Suppl. 2007(188):7-66.
3
Effects of non-surgical treatment modalities on peri-implantitis.非手术治疗方式对种植体周围炎的影响。
Zhonghua Kou Qiang Yi Xue Za Zhi. 2002 May;37(3):173-5.
4
Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis.慢性和侵袭性牙周炎与种植体周围炎的比较生物学。
Periodontol 2000. 2010 Jun;53:167-81. doi: 10.1111/j.1600-0757.2010.00348.x.
5
Short-term clinical and microbiological evaluations of peri-implant diseases before and after mechanical anti-infective therapies.机械抗感染治疗前后种植体周围疾病的短期临床和微生物学评估
Clin Oral Implants Res. 2009 Jan;20(1):99-108. doi: 10.1111/j.1600-0501.2008.01618.x.
6
[Clinical study of periocline on peri-implantitis treatment].[派丽奥治疗种植体周围炎的临床研究]
Zhonghua Kou Qiang Yi Xue Za Zhi. 2006 May;41(5):299-303.
7
Clinical peri-implant sounding accuracy in the presence of chronic inflammation of peri-implant tissues. Clinical observation study.
Minerva Stomatol. 2009 Mar;58(3):81-91.
8
Clinical evaluation of subgingival application of metronidazole 25%, and adjunctive therapy.25%甲硝唑龈下应用及辅助治疗的临床评估
J Int Acad Periodontol. 2000 Jul;2(3):64-70.
9
Cathepsin K levels in the crevicular fluid of dental implants: a pilot study.牙种植体龈沟液中组织蛋白酶K水平:一项初步研究。
J Clin Periodontol. 2006 Apr;33(4):302-8. doi: 10.1111/j.1600-051X.2006.00904.x.
10
Peri-implantitis.种植体周围炎
Dent Clin North Am. 2005 Jul;49(3):661-76, vii-viii. doi: 10.1016/j.cden.2005.03.007.